127 related articles for article (PubMed ID: 9892944)
1. Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay.
Kemp EH; Waterman EA; Gawkrodger DJ; Watson PF; Weetman AP
Br J Dermatol; 1998 Nov; 139(5):798-805. PubMed ID: 9892944
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA).
Kemp EH; Gawkrodger DJ; Watson PF; Weetman AP
Clin Exp Immunol; 1998 Dec; 114(3):333-8. PubMed ID: 9844040
[TBL] [Abstract][Full Text] [Related]
3. Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2).
Kemp EH; Gawkrodger DJ; Watson PF; Weetman AP
Clin Exp Immunol; 1997 Sep; 109(3):495-500. PubMed ID: 9328128
[TBL] [Abstract][Full Text] [Related]
4. Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay.
Kemp EH; Gawkrodger DJ; MacNeil S; Watson PF; Weetman AP
J Invest Dermatol; 1997 Jul; 109(1):69-73. PubMed ID: 9204957
[TBL] [Abstract][Full Text] [Related]
5. Molecular mapping of epitopes on melanocyte-specific protein Pmel17 which are recognized by autoantibodies in patients with vitiligo.
Kemp EH; Waterman EA; Gawkrodger DJ; Watson PF; Weetman AP
Clin Exp Immunol; 2001 Jun; 124(3):509-15. PubMed ID: 11472416
[TBL] [Abstract][Full Text] [Related]
6. Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease.
Ajjan RA; Kemp EH; Waterman EA; Watson PF; Endo T; Onaya T; Weetman AP
J Clin Endocrinol Metab; 2000 May; 85(5):2020-7. PubMed ID: 10843191
[TBL] [Abstract][Full Text] [Related]
7. Identification of epitopes on tyrosinase which are recognized by autoantibodies from patients with vitiligo.
Kemp EH; Waterman EA; Gawkrodger DJ; Watson PF; Weetman AP
J Invest Dermatol; 1999 Aug; 113(2):267-71. PubMed ID: 10469315
[TBL] [Abstract][Full Text] [Related]
8. Tyrosinase as an autoantigen in patients with vitiligo.
Baharav E; Merimski O; Shoenfeld Y; Zigelman R; Gilbrud B; Yecheskel G; Youinou P; Fishman P
Clin Exp Immunol; 1996 Jul; 105(1):84-8. PubMed ID: 8697641
[TBL] [Abstract][Full Text] [Related]
9. Mammalian tyrosinase-related protein-1 is recognized by autoantibodies from vitiliginous Smyth chickens. An avian model for human vitiligo.
Austin LM; Boissy RE
Am J Pathol; 1995 Jun; 146(6):1529-41. PubMed ID: 7778691
[TBL] [Abstract][Full Text] [Related]
10. Characterization of vitiligo antigens.
Cui J; Arita Y; Bystryn JC
Pigment Cell Res; 1995 Feb; 8(1):53-9. PubMed ID: 7792255
[TBL] [Abstract][Full Text] [Related]
11. Vitiligo antibodies are not directed to tyrosinase.
Xie Z; Chen D; Jiao D; Bystryn JC
Arch Dermatol; 1999 Apr; 135(4):417-22. PubMed ID: 10206048
[TBL] [Abstract][Full Text] [Related]
12. The role of tyrosinase in autoimmune vitiligo.
Song YH; Connor E; Li Y; Zorovich B; Balducci P; Maclaren N
Lancet; 1994 Oct; 344(8929):1049-52. PubMed ID: 7934446
[TBL] [Abstract][Full Text] [Related]
13. Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis.
Bermann M; Magee M; Koenig RJ; Kaplan MM; Arscott P; Maastricht J; Johnson J; Baker JR
J Clin Endocrinol Metab; 1993 Oct; 77(4):1098-101. PubMed ID: 8408460
[TBL] [Abstract][Full Text] [Related]
14. Epitopes, avidity and IgG subclasses of tyrosine hydroxylase autoantibodies in vitiligo and alopecia areata patients.
Rahoma SF; Sandhu HK; McDonagh AJ; Gawkrodger DJ; Weetman AP; Kemp EH
Br J Dermatol; 2012 Jul; 167(1):17-28. PubMed ID: 22329856
[TBL] [Abstract][Full Text] [Related]
15. Expression of tyrosinase and the tyrosinase related proteins in the Mitfvit (vitiligo) mouse eye: implications for the function of the microphthalmia transcription factor.
Smith SB; Zhou BK; Orlow SJ
Exp Eye Res; 1998 Apr; 66(4):403-10. PubMed ID: 9593634
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo.
Kemp EH; Emhemad S; Akhtar S; Watson PF; Gawkrodger DJ; Weetman AP
Exp Dermatol; 2011 Jan; 20(1):35-40. PubMed ID: 21158937
[TBL] [Abstract][Full Text] [Related]
17. Reevaluation of the prevalences of serum autoantibodies reactive with "64-kd eye muscle proteins" in patients with thyroid-associated ophthalmopathy.
Kubota S; Gunji K; Stolarski C; Kennerdell JS; Wall J
Thyroid; 1998 Feb; 8(2):175-9. PubMed ID: 9510127
[TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
[TBL] [Abstract][Full Text] [Related]
19. Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo).
Merimsky O; Shoenfeld Y; Baharav E; Zigelman R; Fishman P
Hum Antibodies Hybridomas; 1996; 7(4):151-6. PubMed ID: 9140726
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of autoantibodies against tyrosine hydroxylase in patients with alopecia areata.
Kemp EH; Sandhu HK; Weetman AP; McDonagh AJ
Br J Dermatol; 2011 Dec; 165(6):1236-43. PubMed ID: 21895622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
